Clinical Trials on RRMS

Total 65 results

National Institute of Neurological Disorders and...

Completed

Effects of Transcranial Magnetic Stimulation on Object Recognition

Repetitive TMS (rTMS) | Sham rTMS | Bilateral rTMS | Unilateral rTMS

United States
The Sixth Affiliated Hospital of Wenzhou Medical...
Zhejiang Qixin Biotech

Unknown

Integrin β7, BCMA, CS1, CD38 and CD138 as the Single or Compound Targets for the Fourth Genenation of CAR-T Cells

RRMM

China
First Affiliated Hospital of Zhejiang University

Recruiting

Effect of iTBS on Children With ADHD

ADHD | rTMS

China
University of Manchester

Suspended

The Effects of Cerebellar rTMS on Brain Activity

The Effects of Cerebellar rTMS on the Brain

United Kingdom
Genesis Pharma CNS & Specialty

Completed

Study to Assess Resource Utilization and Quality of Life of Patients With RRMS Treated With Tecfidera in Greece (FIDELITY)

RRMS

Greece
Oncopeptides AB

Terminated

A PK, Safety and Tolerability Study of Peripheral and Central Infusion of Melflufen in RRMM Patients (PORT)

RRMM

Bulgaria, United States, Czechia, Hungary, Ukraine
Duke University

Withdrawn

Effects of rTMS on Human Brain Activity

Repetitive Transcranial Magnetic Stimulation (rTMS)

United States
Derming SRL

Completed

Aesthetic Performance of an Injective Treatment for the Inner Thighs, Knees and Arms

Skin Flaccidity Inner Thighs Knees Arms

Italy
Amsterdam UMC, location VUmc
Radboud University Medical Center; Maastricht University Medical Center; GGZ... and other collaborators

Recruiting

TMS for Exposure Therapy Resistant OCD (TETRO)

1 Hz Real rTMS to the Pre-SMA | 1 Hz Sham rTMS to the Pre-SMA

Netherlands
Derming SRL

Completed

Aesthetic Performance of an Injective Treatment for the Skin Roughness and Laxity of Inner Arm and Abdomen

Skin Flaccidity and Roughness of the Abdomen and Inner Arms

Italy
Ministry of Health, Rwanda

Completed

An Open Label, Blinded Assessor, Trial Comparing Odor Levels Due to Different Hygiene Methods With PrePexTM (RMC-10)

Odor Levels of Study Arms

Rwanda
Ziv Hospital

Unknown

Deficient Lower Segment Cesarean Section Scar, Does the Type of Suture Matter?

2 Arms, Conventional Suture, Barbed Suture
VA Office of Research and Development

Completed

rTMS for Emotional Difficulties in Verterans (rTMS)

Depression | PTSD | Anxiety | Mental Health | Psychosocial Impairment | rTMS

United States
Novartis Pharmaceuticals

Completed

Optical Coherence Tomography (OCT) Trial in Multiple Sclerosis (OCTIMS)

Multiple Sclerosis | RRMS

Spain, Czechia, Germany, Australia, Italy, Switzerland, Denmark, United States, United Kingdom, Canada, Netherlands, Poland
Bayer

Completed

Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon Treatment (BEACON)

Relapsing Remitting Multiple Sclerosis (RRMS)

China, Slovakia, France, Germany, Korea, Republic of, Saudi Arabia, Singapore, Sweden, Taiwan, Colombia, Czech Republic, Estonia, Italy, Jordan, Lebanon, Mexico, Slovenia, United Kingdom, Argentina, Bahrain, Egypt, United Arab Emirates and more
Centre hospitalier de Ville-Evrard, France

Recruiting

Treatment of Resistant Depression by Repetitive Transcranial Magnetic Stimulation (rTMS) Multicentric Naturalistic Study (DSNATUR)

To Evaluate the Effectiveness of Open rTMS

France
Second Affiliated Hospital, School of Medicine,...

Completed

Mechanism of Analgesic Effect on Prolonged Continuous Theta Burst Stimulation

Chronic Pain | rTMS

China
National Taiwan University Hospital

Completed

Management and Outcome of Work-Related Musculoskeletal Disorders

Neck Injury | Back Injury | Arms Injury | Cumulative Disorder

Taiwan
Novartis Pharmaceuticals

Completed

A 3-year Multi-center Study to Describe Changes of OCT Parameters Under Treatment With Gilenya® (PASSOS)

Relapsing Remitting Multiple Sclerosis RRMS

Germany, Switzerland
Novartis Pharmaceuticals

Terminated

MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone (ASSESS)

Relapsing-remitting Multiple Sclerosis (RRMS)

United States, Canada, Mexico, Brazil, Puerto Rico, Argentina, Chile
GE Healthcare
Centre for Probe Development and Commercialization

Completed

Assess Safety, Bio-distribution, Radiation Dosimetry and Optimize the Imaging Protocol of GEH120714 (18F) Injection in Healthy Volunteers and Participants With Relapsing and Remitting Multiple Sclerosis (rrMS).

Relapsing-remitting Multiple Sclerosis (rrMS)

Canada
Novartis Pharmaceuticals

Completed

POC-MD MRI-based Trial in Relapsing-remitting Multiple Scler

Relapsing-remitting Multiple Sclerosis | RRMS

Russian Federation, Ukraine, Czech Republic
Merck Sharp & Dohme LLC

Terminated

Study of Pembrolizumab (MK-3475) in Combination With Dinaciclib (MK-7965) in Hematologic Malignancies (MK-3475-155/KEYNOTE-155)

rrCLL | rrMM | rrDLBCL
Biogen

Recruiting

A Study for Tysabri Participant Preference

Relapsing-Remitting Multiple Sclerosis (RRMS)

Germany
Bayer

Completed

BetaPlus Survey - Observational Study to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon® by Using Elements of the BetaPlus Program

Relapsing Remitting MS (RRMS) | Secondary Progressive MS (SPMS)

France, Germany, Korea, Republic of, Saudi Arabia, Spain, Taiwan, Czech Republic, Italy, Jordan, Lebanon, Turkey, Israel, Portugal, Netherlands, Iran, Islamic Republic of
Weill Medical College of Cornell University
Sidney R. Baer, Jr. Foundation

Completed

Cognitive Behavioral Therapy for the Prevention of Paranoia in Adolescents at High Risk

Prodromal Symptoms | ARMS | APS

United States
Pakistan Institute of Living and Learning

Completed

Minocycline and/or Omega-3 Fatty Acids Added to Treatment as Usual for At Risk Mental States (NAYAB)

Psychosis | At Risk Mental State (ARMS)

Pakistan
Bristol-Myers Squibb

Recruiting

A Study to Describe the Persistence With Ozanimod Treatment in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants (AppreZiate)

Relapsing-remitting Multiple Sclerosis (RRMS)

Spain
Biogen

Completed

Plegridy Satisfaction Study in Participants (PLATINUM)

Relapsing-Remitting Multiple Sclerosis (RRMS)

Italy
Polpharma Biologics S.A.

Completed

Efficacy and Safety of the Biosimilar Natalizumab PB006 in Comparison to Tysabri® (Antelope)

Relapsing-Remitting Multiple Sclerosis (RRMS)

Belarus, Ukraine, Georgia, Croatia, Moldova, Republic of, Poland, Serbia
Cinnagen

Completed

Efficacy and Safety of Peginterferon Beta-1a (CinnaGen) in Participants With Relapsing Remitting Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis (RRMS)

Iran, Islamic Republic of
Germans Trias i Pujol Hospital
Ministerio de Sanidad, Servicios Sociales e Igualdad

Completed

Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis (RRMS)

Spain
Novartis Pharmaceuticals

Terminated

Disease Control and Safety in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) Switching From Natalizumab to Fingolimod (TOFIINGO)

Relapsing Remitting Multiple Sclerosis (RRMS)

Germany, Spain, Australia, Israel, Switzerland, Italy, Austria, Greece, Hungary, Czech Republic, Finland
Merck KGaA, Darmstadt, Germany
Smerud Medical Research International AS; Merck Serono Norway

Completed

A Scandinavian Non-interventional Study of Adherence to RebiSmart Administered Rebif New Formulation (RNF) Treatment in Relapsing Remitting Multiple Sclerosis (RRMS) Subjects (SCANSMART)

Relapsing Remitting Multiple Sclerosis (RRMS)

Norway
Immunic AG

Active, not recruiting

MRI Trial to exPlore the efficAcy and Safety of IMU-838 in Relapsing Remitting Multiple Sclerosis (EMPhASIS) (EMPhASIS)

Relapsing-Remitting Multiple Sclerosis (RRMS)

Poland, Bulgaria, Romania, Ukraine
Biogen
AbbVie

Terminated

Efficacy and Safety of Daclizumab in Participants With RRMS Switching From Natalizumab (SUSTAIN)

Relapsing-Remitting Multiple Sclerosis (RRMS)

Italy, United States, Canada, Germany, Puerto Rico
Biogen
Elan Pharmaceuticals

Completed

A Prospective, Open-label, Non-randomized, Clinical Trial to Determine if Natalizumab (Tysabri®) Improves Ambulatory Measures in Relapsing-remitting Multiple Sclerosis (RRMS) Patients (TIMER)

Relapsing Remitting Multiple Sclerosis (RRMS)

Belgium, Mexico, Poland, Romania, Saudi Arabia, Ukraine
EMD Serono
Pfizer

Completed

RNF and Betaseron® Tolerability Study (REFORMS)

Relapsing Remitting Multiple Sclerosis (RRMS)

United States
Samsung Medical Center

Completed

Effect of Cerebral and Cerebellar rTMS in Stroke Patient

Stroke | Repetitive Transcranial Magnetic Stimulation | rTMS | Motor Recovery

Korea, Republic of
Icahn School of Medicine at Mount Sinai
National Institute of Mental Health (NIMH)

Completed

Reducing the Duration of Untreated Psychosis in the United States

First Episode Psychosis (FEP) | At Risk Mental State (ARMS)

United States
Icahn School of Medicine at Mount Sinai

Withdrawn

Sensation, Motion, and Quality of Life on Natalizumab and Off Natalizumab

Relapsing-remitting Multiple Sclerosis (RRMS)

United States
Biogen

Withdrawn

Brimonidine Tartrate for the Treatment of Injection Related Erythema (BRITE)

Relapsing-Remitting Multiple Sclerosis (RRMS)
Centre Hospitalier Universitaire Dijon

Recruiting

Effectiveness of High-frequency rTMS in Reducing Alcohol Consumption in Non-abstinent Patients With an Alcohol Use Disorder (ALCOSTIM)

Alcoholism | rTMS Stimulation

France
Sidnei Epelman

Unknown

Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Rhabdomyosarcoma and Other Soft Tissue Sarcomas

Refractory or Relapsed RMS and Soft Tissue Sarcomas

Brazil
Bayer

Completed

Portuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectors (POR-BetaPlus)

Secondary Progressive Multiple Sclerosis (SPMS) | Relapsing Remitting Multiple Sclerosis (RRMS)

Portugal
Centre for Addiction and Mental Health

Completed

Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Cannabis Use and Cognitive Outcomes in Schizophrenia (rTMSCANSZ)

Schizophrenia | Cognition | Cannabis Use Disorder | Repetitive Transcranial Magnetic Stimulation (rTMS)

Canada
Muriel POUBLANC

Withdrawn

Pretherapeutic Paraaortic Lymphadenectomy in Women With Locally Advanced Cervical Cancer Versus Definitive Chemoradiotherapy (LiLACs)

Overall Survival Comparison Between the 2 Arms
Neuromed IRCCS
University of Rome Tor Vergata

Not yet recruiting

Effects of Ozanimod on Immune-mediated Mechanisms of Neurodegeneration in Multiple Sclerosis - a Preclinical Study

Healthy | Neuromyelitis Optica | Relapsing-Remitting Multiple Sclerosis (RRMS)

Italy
University Hospital, Clermont-Ferrand

Completed

Intraoperative Protective Ventilation in Abdominal Surgery (IMPROVE Study)

Protective Lung Ventilation Using: | Low Tidal Volume (6-8 mL/kg Predicted Body Weight) | PEEP of 6-8 cmH2O | Intraoperative RMs

France
TG Therapeutics, Inc.

Completed

Study to Assess the Efficacy and Safety of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (RMS) ( ULTIMATE 1 ) (ULTIMATE 1)

Relapsing Multiple Sclerosis (RMS)

United States

Clinical Trials on RRMS

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations